Messenger RNA – Page 18 – Communicable Diseases Research

Presence of SARS-CoV-2 antibodies in lactating women and their infants following BNT162b2 messenger RNA vaccine

BNT162b2 메신저 RNA 백신 후 수유 중인 여성과 유아에서 SARS-CoV-2 항체의 존재

Article

Published on 2021-11-012022-09-12
Journal: American journal of obstetrics and gynecology [Category] MERS, SARS, 진단,

[키워드] BNT162b2 Infant lactating women Messenger RNA Presence SARS-CoV-2 antibody Vaccine
[DOI] 10.1016/j.ajog.2021.07.016 PMC 바로가기 [Article Type] Article

Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation

Cardiovascular Medicine

Published on 2021-10-292022-10-31
Journal: Frontiers in Cardiovascular Medicine [Category] COVID-19,

[키워드] cardiogenic Cardiopulmonary Case report Clinical course coronavirus disease COVID-19 COVID-19 vaccination Extracorporeal extracorporeal membrane oxygenation fulminant fulminant myocarditis intensive care messenger Messenger RNA mRNA myocarditis Patient progression Resuscitation RNA Shock Symptom vaccination
[DOI] 10.3389/fcvm.2021.758996 PMC 바로가기 [Article Type] Cardiovascular Medicine

Evaluation of a COVID-19 Vaccine Campaign and SARS-CoV-2 Infection and Mortality Among Adults Aged 60 Years And Older in a Middle-Income Country

Research

Published on 2021-10-292022-10-29
Journal: JAMA Network Open [Category] COVID-19, MERS, SARS,

[키워드] 95% CI age all-cause mortality Analysis association BBIBP-CorV Buenos Aire Buenos Aires causes ChAdOx1 cohort study country COVID-19 COVID-19 infection COVID-19 vaccine death diagnosis of COVID-19 dose doses ecological female finding Follow-up groups implementation Importance incidence individual Infection measure Messenger RNA morbidity morbidity and mortality Mortality objective Occurrence Older outcome outcomes participant Participants Point Poisson regression model populations Pragmatic receive receiving reduce reduction reduction in reduction in mortality Relevance Result SARS-CoV-2 SARS-COV-2 infection setting shown significantly single dose vaccination vaccination schedule Vaccine Vaccines was performed Year
[DOI] 10.1001/jamanetworkopen.2021.30800 PMC 바로가기 [Article Type] Research

Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types

Article

Published on 2021-10-282022-10-30
Journal: Journal of Personalized Medicine [Category] COVID-19,

Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination

Research

Published on 2021-10-262022-10-29
Journal: JAMA Network Open [Category] COVID-19, MERS, SARS,

[키워드] 95% CI adjusted adjusted relative risk age allergic Allergic history allergic reaction allergy anaphylaxis aRR association Care Cohort cohort study COVID-19 COVID-19 vaccination COVID-19 vaccine defined dose eligible employee exposure finding Health highest history hive Importance increased risk individual individuals log mass measure medication Messenger RNA MOST mRNA mRNA COVID-19 vaccine objective participant Point postvaccination Primary outcome protocol receive receiving Relevance reported Result risk risk factor Safe setting Symptom Symptoms the vaccine vaccination Vaccine vaccine administration was used women
[DOI] 10.1001/jamanetworkopen.2021.31034 PMC 바로가기 [Article Type] Research

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

예방 접종을 받은 의료 종사자의 Covid-19 돌발 감염

Article

Published on 2021-10-142022-09-11
Journal: The New England Journal of Medicine [Category] Fulltext, MERS, 변종,

[키워드] 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Ag-RDT Alpha Analysis Antibody titer Antibody titers Antigen assays Asymptomatic B.1.1.7 BNT162b2 Breakthrough infection breakthrough infections Case-control Control coronavirus correlated correlation Ct value cycle threshold diagnostic diagnostic testing Efficacy estimating equation FIVE genomic sequencing geometric mean geometric mean titer geometric mean titers Health care Health care worker health care workers high viral load Infection Messenger RNA Mild mild symptoms MOST N gene Neutralizing antibody titer neutralizing antibody titers occur Occurrence Patient patients positive result predict reported RT-PCR SARS-CoV-2 SARS-CoV-2 detection Secondary infection secondary infections serologic assays severe acute respiratory syndrome Coronavirus Symptom symptomatic tested The B.1.1.7 titers two groups uninfected control Vaccine variant Viral load were assessed worker
[DOI] 10.1056/NEJMoa2109072 PMC 바로가기 [Article Type] Article

Cutaneous adverse reactions after COVID ‐19 vaccines in a cohort of 2740 Italian subjects: An observational study

Observational Study

Published on 2021-10-132022-10-04
Journal: Dermatologic therapy [Category] MERS, SARS, 임상,

Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity

ACE2 및 NRP1 바이러스 수용체의 후성적 표적화는 SARS-CoV-2 감염성을 제한합니다

Research

Published on 2021-10-112022-09-10
Journal: Clinical Epigenetics [Category] MERS, SARS, 유전자 메커니즘, 치료제,

[키워드] 2-propylpentanoic acid ACE-2 ACE2 addition Affect angiotensin Angiotensin-converting enzyme angiotensin-converting enzyme 2 anti-inflammatory effect Antiviral approved BEAS-2B block Caco-2 Cell cell line cell lines cells Clinical use COVID-19 COVID-19 patients Cytokines dampen decrease dose-dependent manner downregulate effective elements Engagement Epigenetic expression genomic gRNA HCoV HCoV-229E HDAC HDAC inhibitor host protein Huh-7 hyperinflammation IL-6 impair Infection Infectious virus infectious viruses Inflammatory cytokine Inflammatory cytokines Inflammatory response inhibit inhibition inhibitor inhibitory activity limit mechanism Messenger RNA mRNAs N protein neuropilin NRP1 Patient Post-infection priming protease Protease activity protein level protein levels receptor reduce reduced reducing Replication Result S protein Safe SARS-CoV-2 SARS-COV-2 infection Serine serine protease serine protease TMPRSS2 severity of COVID-19 shown significantly supplementary material TMPRSS2 TNF-α Treatment treatment for COVID-19 triggered Vaccine Valproic acid Viral viral spread virion virus viruses VSV
[DOI] 10.1186/s13148-021-01168-5 PMC 바로가기 [Article Type] Research

Vaccines against COVID-19: Priority to mRNA-Based Formulations

COVID-19에 대한 백신: mRNA 기반 제형의 우선 순위

Review

Published on 2021-10-112022-09-11
Journal: Cells [Category] MERS, SARS, 신약개발,

Theoretical basis for stabilizing messenger RNA through secondary structure design

AcademicSubjects/SCI00010

Published on 2021-10-112022-10-31
Journal: Nucleic Acids Research [Category] COVID-19, MERS, SARS,

[키워드] Algorithm approach average B.1.1.7 variant B.1.351 changes in cleavage coding Degradation double-stranded effective feature hydrolysis in vitro in vivo increase Messenger RNA mRNA mRNAs platform Probability problem Proteins reduce regions RNA RNA stability robust SARS-CoV-2 spike protein secondary structure sequence stability target protein temperature translation Vaccine
[DOI] 10.1093/nar/gkab764 PMC 바로가기 [Article Type] AcademicSubjects/SCI00010